Assuming it is next step "Approval" by FDA following prelisting with "Clearance" status, expect should give medical world increased confidence and bode well for product expansion particularly in American market, which will hopefully be reflected in rerated share price. Thurs could be interesting!
Assuming it is next step "Approval" by FDA following prelisting...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
-0.040(6.30%) |
Mkt cap ! $238.7M | |||
| Open | High | Low | Value | Volume |
| 64.0¢ | 64.0¢ | 59.5¢ | $516.9K | 842.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 8172 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 37552 | 6 |
View Market Depth
| Last trade - 15.35pm 20/06/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |